New Recommendations Aim to Improve Identification and Management of Serrated Polyposis Syndrome
New consensus recommendations by the U.S. Multi-Society Task Force (MSTF) on Colorectal Cancer (CRC) address serrated polyposis syndrome (SPS), which is the most common gastrointestinal polyp syndrome yet is widely underrecognized. SPS is a clinical syndrome characterized by more serrated lesions and is associated with an increased risk of CRC.
The MSTF offers 11 evidence-based recommendations to increase awareness and identification of SPS among gastroenterologists and surgical endoscopists and offers clinical strategies for improving SPS diagnosis, surgical and endoscopic management, CRC risk and surveillance intervals, and genetic risk assessment.
"These recommendations emphasize recognition of the syndrome, including by tracking numbers of serrated polyps over multiple colonoscopies,” said lead author Douglas K. Rex, MD, MACP, MACG, MASGE, AGAF.
The MSTF includes representatives from the ACG, AGA, and ASGE. This consensus document is published online today in the three societies’ respective scientific journals.
U.S. Multi-Society Task Force on Colorectal Cancer, Serrated Polyposis Syndrome: A Review and Consensus Statement by the U.S. Multi-Society Task Force on Colorectal Cancer
Douglas K. Rex, MD, MACP, MACG, MASGE, AGAF; Joseph C. Anderson, MD, MHCDS, FACG; Carol A. Burke, MD, MACG, AGAF, FASGE; Brian C. Jacobson, MD, MPH, FACG, AGAF, FASGE; Folasade P. May, MD, PhD, MPhil, FACG, AGAF; Swati G. Patel, MD, MS; N. Jewel Samadder, MD, FACG, AGAF; Elena M. Stoffel, MD, MPH; and Douglas J. Robertson, MD, MPH, AGAF
Read in:
The American Journal of Gastroenterology
Gastroenterology
Gastrointestinal Endoscopy